CLL cells overexpress different inhibitory ligands, such as programmed cell death 1 ligand (PD-L1) and HVEM, which bind to PD1 and BTLA, respectively, expressed on cytotoxic T cells and NK cells. This evidence concerns the gene PDCD1 and B-cell chronic lymphocytic leukemia.